Histone arginine methylation keeps RUNX1 target genes in an intermediate state

Oncogene

Volumn 32, Issue 20, 2013, Pages 2565-2575

  Herglotz, J ^a   Kuvardina, O N ^a   Kolodziej, S ^a   Kumar, A ^a   Hussong, H ^a   Grez, M ^a   Lausen, J ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

Epigenetics; Histone modifications; Poised state; RUNX1; Stem cell

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE H3; LENTIVIRUS VECTOR; PROTEIN ARGININE METHYLTRANSFERASE; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HISTONE METHYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ARGININE; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 1; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; K562 CELLS; MEGAKARYOCYTE PROGENITOR CELLS; MEGAKARYOCYTES; METHYLATION; NUCLEAR PROTEINS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN-ARGININE N-METHYLTRANSFERASES;

EID: 84878017819     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.274     Document Type: Article

References (56)

1. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008; 132: 631-644. (Pubitemid 351260057)
2. Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 2007; 128: 747-762. (Pubitemid 46273582)
3. de Laat W, Klous P, Kooren J, Noordermeer D, Palstra RJ, Simonis M et al. Three-dimensional organization of gene expression in erythroid cells. Curr Topics Dev Biol 2008; 82: 117-139.
4. Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat Rev 2007; 8: 263-271. (Pubitemid 46439288)
5. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326.
6. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell stem cell 2009; 4: 80-93.
7. Oguro H, Yuan J, Ichikawa H, Ikawa T, Yamazaki S, Kawamoto H et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell stem cell 2010; 6: 279-286.
8. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 2004; 18: 1592-1605. (Pubitemid 38868910)
9. Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006; 8: 532-538.
10. Orford K, Kharchenko P, Lai W, Dao MC, Worhunsky DJ, Ferro A et al. Differential H3K4 methylation identifies developmentally poised hematopoietic genes. Dev Cell 2008; 14: 798-809. (Pubitemid 351622618)
11. Okuda T, van Deursen J, Hiebert SW, Grosveld G, JR Downing. AML1 the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330. (Pubitemid 26042836)
12. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad SciUSA 1996; 93: 3444-3449. (Pubitemid 26125639)
13. Harada Y, Harada H. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations. J Cell Physiol 2009; 220: 16-20.
14. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991; 88: 10431-10434. (Pubitemid 21915849)
15. Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005; 106: 494-504. (Pubitemid 40981243)
16. Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004; 10: 299-304. (Pubitemid 38667622)
17. Owen CJ, Toze CL, Koochin A, Forrest DL, Smith CA, Stevens JM et al. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood 2008; 112: 4639-4645.
18. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166-175. (Pubitemid 29455388)
19. Ben-Ami O, Pencovich N, Lotem J, Levanon D, Groner Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc Natl Acad Sci USA 2009; 106: 238-243.
20. Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, AN Goldfarb. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 2003; 101: 4333-4341. (Pubitemid 36857797)
21. Satoh Y, Matsumura I, Tanaka H, Ezoe S, Fukushima K, Tokunaga M et al. AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells. J Biol Chem 2008; 283: 30045-30056.
22. Pencovich N, Jaschek R, Tanay A, Groner Y. Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. Blood 2010; 117: e1-14.
23. Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 2008; 22: 640-653. (Pubitemid 351342436)
24. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 1998; 17: 2994-3004. (Pubitemid 28254372)
25. Wang L, Huang G, Zhao X, Hatlen MA, Vu L, Liu F et al. Post-translational modifications of Runx1 regulate its activity in the cell. Blood cells, molecules & diseases. Blood Cells Mol Dis 2009; 43: 30-34.
26. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009; 33: 1-13.
27. Shilatifard A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 2008; 20: 341-348.
28. Kirmizis A, Santos-Rosa H, Penkett CJ, Singer MA, Vermeulen M, Mann M et al. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 2007; 449: 928-932. (Pubitemid 47598603)
29. Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007; 449: 933-937. (Pubitemid 47598605)
30. Iberg AN, Espejo A, Cheng D, Kim D, Michaud-Levesque J, Richard S et al. Arginine methylation of the histone H3 tail impedes effector binding. J Biol Chem 2008; 283: 3006-3010.
31. Hyllus D, Stein C, Schnabel K, Schiltz E, Imhof A, Dou Y et al. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 2007; 21: 3369-3380. (Pubitemid 350277762)
32. Xu G, Kanezaki R, Toki T, Watanabe S, Takahashi Y, Terui K et al. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome. Leukemia 2006; 20: 1002-1008. (Pubitemid 43797291)
33. Michaud-Levesque J, Richard S. Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 2009; 284: 21338-21346.
34. Hoogenkamp M, Krysinska H, Ingram R, Huang G, Barlow R, Clarke D et al. The Pu. 1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis. Mol Cell Biol 2007; 27: 7425-7438. (Pubitemid 350033650)
35. Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z et al. PU. 1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet 2008; 40: 51-60.
36. Wang W, Schwemmers S, Hexner EO, Pahl HL. AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2. Blood 2010; 116: 254-246.
37. Zhang X, Cheng X. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 2003; 11: 509-520. (Pubitemid 36579129)
38. Wilson NK, Calero-Nieto FJ, Ferreira R, Gottgens B. Transcriptional regulation of haematopoietic transcription factors. Stem Cell Res Ther 2011; 2: 6.
39. Hannah R, Joshi A, Wilson NK, Kinston S, Gottgens B. A compendium of genomewide hematopoietic transcription factor maps supports the identification of gene regulatory control mechanisms. Exp Hematol 2011; 39: 531-541.
40. Kowenz-Leutz E, Pless O, Dittmar G, Knoblich M, Leutz A. Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J 2010; 29: 1105-1115.
41. Sims 3rd RJ, Reinberg D. Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol 2008; 9: 815-820.
42. Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008; 9: 702-712.
43. O'Malley BW, Qin J, Lanz RB. Cracking the coregulator codes. Curr Opin Cell Biol 2008; 20: 310-315.
44. Elagib KE, Goldfarb AN. Regulation of RUNX1 transcriptional function by GATA-1. Critical reviews in eukaryotic gene expression 2007; 17: 271-280. (Pubitemid 47015557)
45. Goldfarb AN. Megakaryocytic programming by a transcriptional regulatory loop: a circle connecting RUNX1, GATA-1, and P-TEFb. J Cell Biochem 2009; 107: 377-382.
46. Jiang H, Zhang F, Kurosu T, Peterlin BM. Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing. Mol Cell Biol 2005; 25: 10675-10683. (Pubitemid 41747114)
47. Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, Burlingame AL et al. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 2005; 121: 859-872. (Pubitemid 40806418)
48. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007; 25: 15-30. (Pubitemid 46049068)
49. Yu M, Mazor T, Huang H, Huang HT, Kathrein KL, Woo AJ et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell 2012; 45: 330-343.
50. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125: 301-313. (Pubitemid 44313811)
51. Hammoud SS, Nix DA, Zhang H, Purwar J, Carrell DT, Cairns BR. Distinctive chromatin in human sperm packages genes for embryo development. Nature 2009; 460: 473-478.
52. Hoogenkamp M, Lichtinger M, Krysinska H, Lancrin C, Clarke D, Williamson A et al. Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 2009; 114: 299-309.
53. Balint BL, Szanto A, Madi A, Bauer UM, Gabor P, Benko S et al. Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells. Mol Cell Biol 2005; 25: 5648-5663. (Pubitemid 40853599)
54. Mahajan MC, Karmakar S, Newburger PE, Krause DS, Weissman SM. Dynamics of alpha-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34(+) cells in culture. Exp Hematol 2009; 37: 1143-1156e3.
55. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803-813. (Pubitemid 34493974)
56. Lausen J, Cho S, Liu S, Werner MH. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO. J Biol Chem 2004; 279: 49281-49288. (Pubitemid 39625814)